Abstract
The chikungunya virus (CHIKV) causes a devastating musculoskeletal inflammatory disease with symptoms of headache, rash, polyarthralgia, fever and myalgia. CHIKV has appeared intermittently around the world and in different ecological zones of Pakistan. Aedes mosquito species are the main vectors of CHIKV transmission and cause high disease rates in the urban transmission cycle. Even though the CHIKV is responsible for many cases of disease, no authorized antibodies or antiviral treatments are available, and prevention is the primary countermeasure. This review describes an update on CHIKV molecular biology, replication cycle, epidemiology, ecological factors, clinical manifestations and treatment and suggests a way forward to control and prevent this infection strategically in the future.
References
- 1. Chikungunya virus infection: an overview. New Microbiol. 36(3), 211–227 (2013).
- 2. Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents. Acta. Pharma. Sin. B. 5(4), 285–299 (2015).
- 3. Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J. Gen. Virol. 83(12), 3075–3084 (2002).
- 4. Regulation of the sequential processing of Semliki Forest virus replicase polyprotein. J. Bio. Chem. 278(43), 41636–41645 (2003).
- 5. Membrane binding mechanism of an RNA virus-capping enzyme. J. Biol. Chem. 275(48), 37853–37859 (2000).
- 6. . Expression of Sindbis virus nsP1 and methyltransferase activity in Escherichia coli. Virol. J. 184(1), 423–427 (1991).
- 7. . Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. PNAS. 92(2), 507–511 (1995).
- 8. . Processing the nonstructural polyproteins of sindbis virus: nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans. J. Virol. 63(11), 4653–4664 (1989).
- 9. . Site-specific protease activity of the carboxyl-terminal domain of Semliki Forest virus replicase protein nsP2. J. Biol. Chem. 276(33), 30786–30793 (2001).
- 10. The crystal structures of chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J. Virol. 83(13), 6534–6545 (2009).
- 11. Nucleotide sequence of cDNA coding for Semliki Forest virus membrane glycoproteins. Nature 288(5788), 236 (1980).
- 12. Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein. Virology 169(2), 485–488 (1989).
- 13. . Semliki Forest virus particles containing only the E1 envelope glycoprotein are infectious and can induce cell-cell fusion. Virology 166(1), 17–23 (1988).
- 14. . pH-induced alterations in the fusogenic spike protein of Semliki Forest virus. J. Cell. Bio. 101(6), 2284–2291 (1985).
- 15. . Individual expression of Sindbis virus glycoproteins. E1 alone promotes cell fusion. Virology 305(2), 463–472 (2003).
- 16. . Role of spike protein conformational changes in a fusion of Semliki Forest virus. J. virol. 67(12), 7597–7607 (1993).
- 17. . Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J. Virol. 66(12), 7309–7318 (1992).
- 18. . The reappearance of chikungunya, formerly called dengue, in the Americas. Emerg. Infect. Dis. 21(4), 557 (2015).
- 19. . Chikungunya and dengue: a case of mistaken identity? J. His. Med. Allied Sci. 26(3), 243–262 (1971).
- 20. . The dengue group of viruses and its family relationships. Bacteriol. Rev. 14(3), 225–232 (1950).
- 21. . Dengue and chikungunya virus infection in man in Thailand, 1962–1964. Am. J. Trop. Med. Hyg. 18(6), 997–1021 (1969).
- 22. . Observations related to the pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. YJBM 42(5), 311 (1970).
- 23. . Concurrent isolation from a patient of two arboviruses, chikungunya and dengue type 2. Science. 157(3794), 1307–1308 (1967).
- 24. The global distribution and burden of dengue. Nature 496(7446), 504 (2013).
- 25. . Global spread and persistence of dengue. Annu. Rev. Microbiol. 62, 71–92 (2008).
- 26. . A review on chikungunya and suggesting a hypothesis of nano-based drug delivery. Biosci. Biotechnol. Res. Asia. 11(1), 155–158 (2014).
- 27. Chikungunya virus infection. Curr. Infect. Dis.Rep. 13(3), 218 (2011).
- 28. . Quantitative genetics of Aedes aegypti vector competence for dengue viruses: towards a new paradigm? Trends. Parasitol. 27(3), 111–114 (2011).
- 29. . A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathol. 3(12), e201 (2007).
- 30. . Emerging arboviruses in the Pacific. Lancet 384(9954), 1571–1572 (2014).
- 31. . Rapid spread of emerging Zika virus in the Pacific area. Clin. Microbiol. Infect. 20(10), O595–O596 (2014).
- 32. . Zika virus: following the path of dengue and chikungunya? Lancet 386(9990), 243–244 (2015).
- 33. . The burden of chikungunya in the Pacific. Clin. Microbiol. Infect. 21(6), e47–48 (2015).
- 34. . Transcontinental movement of Asian genotype chikungunya virus. Emerg. Infect. Dis. 20(8), 1400 (2014).
- 35. Genomic epidemiology of chikungunya virus in Colombia reveals genetic variability of strains and multiple geographic introductions in outbreak, 2014. Sc. Rep. 9(1), 1–11 (2019).
- 36. Epidemiological trend of chikungunya outbreak in Pakistan: 2016–2018. PLoS. Neg. Trop. Dis. 13(4), e0007118 (2019).
- 37. A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans. R. Soc. Trop. Med. Hyg. 77(4), 442–445 (1983).
- 38. Potential role of phytohormones and plant growth-promoting rhizobacteria in abiotic stresses: consequences for changing environment. Environ. Sci. Pollut. Res. 22(7), 4907–4921 (2015).
- 39. . Awareness among barbers about health hazards associated with their profession. J. Ayub. Med. Coll. Abbottabad. 20(2), 35–38 (2008).
- 40. Outbreaks of chikungunya in Pakistan. Lancet. Infect. Dis. 17(5), 483 (2017).
- 41. . Outbreak of chikungunya in Pakistan. Lancet. Infect. Dis. 17(3), 258 (2017).
- 42. Commentary: outbreak of chikungunya in Pakistan. Front. Public. Health. 5, 261 (2017).
- 43. . Chikungunya: Evolutionary history and recent epidemic spread. Antiviral Res. 120, 32–39 (2015).
- 44. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J. Virol. 84(13), 6497–6504 (2010).
- 45. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 393(2), 183–197 (2009).
- 46. . Vectors of chikungunya virus in Senegal: current data and transmission cycles. Am. J. Trop. Med. Hyg. 60(2), 281–286 (1999).
- 47. . Oviposition, dispersal, and survival in Aedes aegypti: implications for the efficacy of control strategies. Vector-Borne Zoonotic Dis. 7(2), 261–273 (2007).
- 48. Drought-associated chikungunya emergence along coastal East Africa. Am. J. Trop. Med. Hyg. 76(3), 405–407 (2007).
- 49. The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci. Data. 2, 150035 (2015).
- 50. Aedes albopictus, an arbovirus vector: from the darkness to the light. Microb. Infect. 11(14–15), 1177–1185 (2009).
- 51. . The invasive mosquito species Aedes albopictus: current knowledge and future perspectives. Trends. Parasitol. 29(9), 460–468 (2013).
- 52. Host choice and West Nile virus infection rates in blood-fed mosquitoes, including members of the Culex pipiens complex, from Memphis and Shelby County, Tennessee, 2002–2003. Vector-Borne Zoonotic Dis. 7(3), 365–386 (2007).
- 53. Aedes hensilli as a potential vector of chikungunya and Zika viruses. PLoS Neg. Trop. Dis. 8(10), e3188 (2014).
- 54. . Dengue fever: diagnosis and treatment. Exp. Rev. Anti-Infect. 8(7), 841–845 (2010).
- 55. . A review of chikungunya virus-induced arthralgia: clinical manifestations, therapeutics, and pathogenesis. Open Rheumatol. J. 10, 129 (2016).
- 56. . Chikungunya fever: a review of a reemerging mosquito-borne infectious disease and the current status. Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology. Formatex Research Center, Badajoz, Spain, 597–606 (2010).
- 57. . Chikungunya fever: clinical manifestations & management. Indian J. Med. Res. 124(5), 471 (2006).
- 58. . Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med. Clin. N. Am. 92(6), 1323–1343 (2008).
- 59. . Mucocutaneous features of chikungunya fever: a study from an outbreak in West Bengal, India. Int. J. Dermatol. 47(11), 1148–1152 (2008).
- 60. . Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 88(9), 2363–2377 (2007).
- 61. Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India. Int. J. Dermatol. 47(2), 154–159 (2008).
- 62. . Chikungunya: first steps toward specific treatment and prophylaxis. J. Infect. Dis. 200(4), 489–491 (2009).
- 63. . Epidemiology, clinical manifestations, and diagnosis of chikungunya fever: lessons learned from the re-emerging epidemic. Indian J. Dermatol. 55(1), 54 (2010).
- 64. Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Reunion. Epidemiol. Infect. 137(4), 534–541 (2009).
- 65. . Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever). Br. Heart. J. 34(8), 821 (1972).
- 66. . Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever – a follow-up study. Am. Heart. J. 85(2), 186–194 (1973).
- 67. . Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 7(5), 319–327 (2007).
- 68. . Rheumatoid arthritic syndrome after chikungunya fever. S. Afr. Med. J. 56(4), 130–132 (1979).
- 69. . Chikungunya viral arthropathy: a clinical description. J. rheumatol. 7(2), 231–236 (1980).
- 70. . Chikungunya virus infection – a retrospective study of 107 cases. S. Afr. Med. J. 68(9), 313–315 (1983).
- 71. Characterization of a chikungunya virus strain isolated from banked patients’ sera. Virol. J. 13(1), 150 (2016).
- 72. Organization WH. World health statistics 2011. World Health Stat. WHO, Geneva, Switzerland (2011).
- 73. . HIV-TB co-infection: epidemiology, diagnosis & management. Indian J. Med. Res. 121(4), 550–567 (2005).
- 74. . Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis. 49(6), 942–948 (2009).
- 75. MBOC6 Custom Textbook – University of Toronto - BIO230H. Mol. Biol. Cell. (2015).
- 76. WHO, UNICEF. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. (2009).
- 77. . An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953. Trans. R. Soc. Trop. Med. Hyg. 49(1), 28–32 (1955).
- 78. . Chloroquine phosphate treatment of chronic chikungunya arthritis. An open pilot study. S. Afr. Med. J. 66(6), 217–218 (1984).
- 79. On chikungunya acute infection and chloroquine treatment. Vector-Borne Zoonotic Dis. 8(6), 837–840 (2008).
- 80. Combination of N-methylisatin-β-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the anti-viral activity of SCH16 against Japanese encephalitis virus in vitro. Lett. Appl. Microbiol. 55(3), 234–239 (2012).
- 81. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 7(12), 1091–1098 (2008).
- 82. . Prospects for better tuberculosis vaccines. Lancet. Infect. Dis. 1(1), 21–28 (2001).
- 83. . Chikungunya virus vaccines: current strategies and prospects for developing plant-made vaccines. Vaccine. 33(31), 3650–3658 (2015).
- 84. Seasonality in hospital admissions of Crimean–Congo hemorrhagic fever and its dependence on ambient temperature – empirical evidence from Pakistan. Int. J. Biometeorol. 61(11), 1893–1897 (2017).
- 85. First chikungunya outbreak in Pakistan: a trail of viral attacks. New Microbes New Infect. 19, 13–14 (2017).
- 86. Dengue: a continuing global threat. Nat. Rev. Microbiol. 8(Suppl. 12), S7 (2010).
- 87. . Mathematics Teacher Noticing: Seeing through Teachers’ Eyes. Routledge, NY, USA (2011).
- 88. An epidemic of Dengue fever in Karachi – associated clinical manifestations. JPMA. J. Pak. Med. Assoc. 47(7), 178–181 (1997).
- 89. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke. 42(5), 1237–1243 (2011).
- 90. Dynamics and diversity of bacteria associated with the disease vectors Aedes aegypti and Aedes albopictus. Sci. Rep. 9(1), 1–12 (2019).
- 91. FHL1 is a major host factor for chikungunya virus infection. Nature. 574(7777), 259–263 (2019).